ARTDAI Launches ArtExpert 3.0 Data Platform
AE3 addresses long-standing data standardization issues in the fine art auction market. Auction houses use disparate data formats and cataloging conventions, creating a fragmented information landscape that complicates market analysis and transaction workflows.
"Getting auction data is easy - anyone can spin up a scraper or purchase a data feed. The hard part is what to do with raw data, especially when data quality issues cause delays and errors in business processes and client proposals," said
ArtExpert 3.0 Platform Capabilities:
- Real-time data publication with auction catalogs and results available within hours of sale
- Structured data enabling granular filtering across artist, medium, period, geography, and price parameters
- Direct auction house source links for transaction verification and audit compliance
- Proprietary data normalization supporting quantitative market analysis and indexing
- Vertical-specific AI models trained on proprietary auction market datasets
Enterprise Applications
"We're working with insurers, lenders, family offices, and art market enterprises to provide the data infrastructure for fine art and collectible assets – enabling portfolio analysis, market intelligence and risk assessment that wasn't previously possible at scale," said
AE3 operates under ISO-27001 security standards and will be embedded in ARTDAI's enterprise solutions.
About ARTDAI
ARTDAI provides art & collectibles market data and workflow tools to art professionals, collectors, financial institutions, and marketplaces. By combining up-to-date market information with advanced analytics, ARTDAI provides its users with best-in-class research and mission-critical market insights. Founded in 2017, ARTDAI has offices in Newmarket and
For more information, visit www.artd.ai
Media Contact:
VP, Growth
[email protected]
View original content:https://www.prnewswire.com/news-releases/artdai-launches-artexpert-3-0-data-platform-302658749.html
SOURCE ARTDAI
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formu
- Costerfield – True Blue Exploration Update
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Provides New Details on FF’s Robotics Q3 Campaign, EAI Robotics Summer Camps and Insight Into FF’s Delivery, Service, an
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share